Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Clostridioides (formerly Clostridium) difficile infection is a common and costly healthcare-associated infection. Extraintestinal C. difficile infection is rarely encountered, especially in isolation. We present a unique case of abdominal wall abscess presenting six months following gastrointestinal...

Bibliografski detalji
Glavni autori:	Justine Chinnappan, Murtaza Hussain, Dominic Awuah, Ekwevugbe Ogbon, Ghassan Bachuwa, Philip McDonald
Format:	Članak
Jezik:	English
Izdano:	SMC MEDIA SRL 2023-02-01
Serija:	European Journal of Case Reports in Internal Medicine
Teme:	extraintestinal cdi abdominal wall abscess persistent c. difficile abscess
Online pristup:	https://www.ejcrim.com/index.php/EJCRIM/article/view/3711

Slični predmeti

Treatment of Extra-Intestinal Clostridioides difficile Abscess following Acute Appendicitis
od: Tulika Chatterjee, i dr.
Izdano: (2022-09-01)

Splenic Abscess Caused by Clostridium difficile
od: Chee Yik Chang, i dr.
Izdano: (2023-08-01)

Extraintestinal <i>Clostridioides difficile</i> Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature
od: Edit Urbán, i dr.
Izdano: (2020-01-01)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
od: Kullar R, i dr.
Izdano: (2020-10-01)

Editorial: Clostridioides difficile infection
od: Guido Granata, i dr.
Izdano: (2024-02-01)

Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study
od: Danilo Buonsenso, i dr.
Izdano: (2022-04-01)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
od: Silvia Vázquez-Cuesta, i dr.
Izdano: (2023-04-01)

Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
od: Duolong Zhu, i dr.
Izdano: (2018-02-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
od: Kristina Rizzardi, i dr.
Izdano: (2018-09-01)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)
od: Sahil Khanna, i dr.
Izdano: (2022-09-01)

Case report: post-salmonellosis abscess positive for Salmonella Oranienburg
od: Brenda M. Castlemain, i dr.
Izdano: (2022-04-01)

Prevalence, antibiogram, phenotypic and genotypic analysis of Clostridioides difficile toxigenic strains from stool samples
od: Mohammed A. Alqasem, i dr.
Izdano: (2023-08-01)

Pathogenicity and virulence of Clostridioides difficile
od: Jessica E. Buddle, i dr.
Izdano: (2023-12-01)

Recognition, Diagnosis, and Treatment of <i>Clostridioides difficile</i> Enterocolitis Presenting Without Diarrhea: A Literature Review
od: Ezgi Yılmaz, i dr.
Izdano: (2025-02-01)

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
od: Chinenye M. Okafor, i dr.
Izdano: (2023-05-01)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
od: Laura Tijerina-Rodríguez, i dr.
Izdano: (2022-02-01)

Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI)
od: Carolin F. Manthey, i dr.
Izdano: (2019-12-01)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
od: Ting Gu, i dr.
Izdano: (2022-08-01)

Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022
od: Orna Schwartz, i dr.
Izdano: (2023-12-01)

Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation
od: Omar Ahmad, i dr.
Izdano: (2021-06-01)

Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine
od: Abukhalil AD, i dr.
Izdano: (2021-11-01)

Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
od: Pedro Puerta-Alcalde, i dr.
Izdano: (2025-04-01)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
od: Teena Chopra, i dr.
Izdano: (2023-01-01)

Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
od: Guido Granata, i dr.
Izdano: (2022-10-01)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
od: Marta Hernández, i dr.
Izdano: (2019-01-01)

Clostridium difficile Bacteremia as a Rare Presentation of Polymicrobial Pyogenic Liver Abscesses and Its Management Challenges
od: Junghyun Lim, i dr.
Izdano: (2023-09-01)

Characterization of a Clostridioides difficile outbreak caused by PCR ribotype 046, associated with increased mortality
od: Cecilia Magnusson, i dr.
Izdano: (2022-12-01)

Patient Experiences with Clostridioides difficile Infection: Results of a Canada-Wide Survey
od: Vent-Schmidt J, i dr.
Izdano: (2020-01-01)

The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
od: Nicholas A. Lesniak, i dr.
Izdano: (2022-08-01)

A Case Report and Review of the Literature: Reactive Arthritis Caused by Clostridioides difficile ribotype 027
od: Ortrud Zimmermann, i dr.
Izdano: (2022-02-01)

Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
od: Daniele Roberto Giacobbe, i dr.
Izdano: (2022-10-01)

Clostridioides difficile infection in infants: a case report and literature review
od: Zhirong Li, i dr.
Izdano: (2023-06-01)

Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008–2015
od: Veronica Zanichelli, i dr.
Izdano: (2020-06-01)

Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples
od: Dae Hyeon Cho, i dr.
Izdano: (2024-04-01)

ESTRATÉGIAS PARA REDUÇÃO DOS CASOS DE CLOSTRIDIOIDES DIFFICILE NA UNIDADE DE TERAPIA INTENSIVA: ABORDAGEM MULTIFATORIAL
od: Luciana Rodrigues da Silva, i dr.
Izdano: (2023-10-01)

Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease
od: Charlotte Nyblade, i dr.
Izdano: (2022-06-01)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
od: Elaine Finn, i dr.
Izdano: (2021-05-01)

Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis
od: Sevliya Öcal Demir, i dr.
Izdano: (2021-12-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
od: Ronald G. Hall, i dr.
Izdano: (2022-02-01)

Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case–control study
od: Min Hyung Kim, i dr.
Izdano: (2022-01-01)